Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol’s Buy of Inhibitex for Hepatitis Drug Won’t Be Last
Bristol’s Buy of Inhibitex for Hepatitis Drug Won’t Be Last
Bristol’s Buy of Inhibitex for Hepatitis Drug Won’t Be Last
Submitted by
admin
on January 9, 2012 - 10:12am
Source:
Bloomberg
News Tags:
Bristol-Myers Squibb
M&A
Inhibitex
hepatitis C
Headline:
Bristol’s Buy of Inhibitex for Hepatitis Drug Won’t Be Last
Do Not Allow Advertisers to Use My Personal information
